On March 28, 2022 ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, reported their participation in upcoming investor conferences and invites investors to participate in one-on-one meetings (Press release, ERYtech Pharma, MAR 28, 2022, View Source [SID1234611127]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investor Access Event

Link to the event

Date: Monday, April 4th and Tuesday, April 5th
Place: Paris (France)
Participant: Eric SOYER (CFO-COO)

Kempen 14th Life Sciences Conference

Link to the event

Date: Thursday, April 21st
Place: Amsterdam (Netherlands)
Participants: Gil BEYEN (CEO) and Eric SOYER (CFO-COO)

If you are interested in arranging a one-on-one meeting, please contact your conference representative.